HALO logo
halo search icon
Alterity Therapeutics Ltd. Sponsored ADR
Alterity Therapeutics Ltd. Sponsored ADR
ATHE · NAS

Alterity Therapeutics Ltd. Sponsored ADR

US$4.27

0.00 (0.00%)
20/05/2026 04:00:01 PM
All-ConsensusHammer Bearish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Alterity Therapeutics Ltd. Sponsored ADR Overview

ATHE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ATHE

icon

Telephone

61.3.9349.4906

icon

Address

Suite 4, Level 14, 350 Collins Street, Melbourne, Victoria (VIC) 3000

Description

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

ATHE Price Chart

Key Stats

Market Cap

US$73.20M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.66 - 7

Trade Value (12mth)

US$59,540.00

1 week

5.96%

1 month

-12.05%

YTD

35.13%

1 year

6.48%

All time high

797.40

Key Fundamentals

EPS 3 yr Growth

-68.20%

EBITDA Margin

0.00%

Operating Cashflow

-$7m

Free Cash Flow Return

-40.00%

ROIC

-42.40%

Interest Coverage

0.00

Quick Ratio

13.00

Other Data

Shares Outstanding (Fully Diluted)

17m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ATHE Announcements

Latest Announcements

DateAnnouncements
19 May 26
12 May 26
11 May 26
07 May 26
30 April 26

ATHE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.3-2.06-0.74locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.3-2.06-0.74locklocklock
Growth
%locklocklocklock1.210.364.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS)?
Halo FAQ
The current share price of Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) is USD$4.27.
What is the 52-week high share price for Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS)?
Halo FAQ
The 52-week high share price for Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) is USD$7.00.
What is the 52-week low share price for Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS)?
Halo FAQ
The 52-week low share price for Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) is USD$2.66.
What is the dividend yield for Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS)?
Halo FAQ
Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) does not pay a dividend.
What was Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) last dividend payment?
Halo FAQ
Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) does not pay a dividend.
What is the franking level for Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS)?
Halo FAQ
Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) has a franking level of 0.00%.
In which sector is Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) classified?
Halo FAQ
Alterity Therapeutics Ltd. Sponsored ADR (ATHE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.